Cost of Managing Stage IV Breast Cancer in the UK
Author Information
Author(s): Remák E, Brazil L
Primary Institution: MEDTAP International and Breakthrough Breast Cancer
Hypothesis
The study investigates the current treatment patterns and economic burden associated with stage IV breast cancer in the UK.
Conclusion
The estimated direct cost of lifetime treatment for all patients in the UK presenting with stage IV breast cancer is approximately £26 million per year.
Supporting Evidence
- Breast cancer caused over 12,000 deaths in the UK in 2000.
- 70% of patients receive some form of endocrine therapy during the active-treatment phase.
- The median survival for patients diagnosed with stage IV breast cancer is 18 months.
- The total number of newly diagnosed patients in the UK with stage IV breast cancer was estimated to be 2070.
Takeaway
This study looks at how much it costs to treat women with advanced breast cancer in the UK, which is a lot of money.
Methodology
The study used an incidence approach to estimate the lifetime cost of treatment for female patients diagnosed with stage IV breast cancer, analyzing data from cancer registries and a panel of cancer physicians.
Potential Biases
Potential bias exists as the data was collected from a panel of physicians who may not represent all treatment practices.
Limitations
The study may underestimate the economic burden due to incomplete cancer registry data and the inability to track disease progression in earlier stages.
Participant Demographics
The study focused on female patients diagnosed with stage IV breast cancer in the UK.
Statistical Information
Confidence Interval
95% CI: £9008–£16,701
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website